Palatin technologies Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Palatin technologies Contact Number

Palatin Technologies Contact Us

8 hours ago Palatin.com Show details

(609) 495-2200To learn more about our pipeline, investment outlook, and potential, or to submit a general inquiry, please use the form below. General inquiries: [email protected]palatin.com. Investor information: [email protected]palatin.com. Employment opportunities: [email protected]palatin.com. Business development inquiries: [email protected]palatin.com.

1. 4-B Cedar Brook Drive Cedar Brook Corporate, Center Cranbury, NJ 08512

Category: Contact Support, Tech SupportShow more

Palatin Technologies Home

Just Now Palatin.com Show details

We discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions. Chronic inflammation is a consequence of many diseases, but current treatments often do not strike the right balance between efficacy, safety, and tolerability—leading to frustration for the patient and the physician alike.

Category: Home Phone, Tech SupportShow more

Palatin Technologies Crunchbase Company Profile & Funding

Just Now Crunchbase.com Show details

609-495-2200Contact Email [email protected]palatin.com Phone Number 609-495-2200 We are a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

Founded: 1986
Founder: Carl Spana

Category: Tech SupportShow more

Contact Us Palantir

3 hours ago Palantir.com Show details

We build software that empowers organizations to effectively integrate their data, decisions, and operations.

Category: Contact SupportShow more

Palatin Technologies Company Profile Office Locations

7 hours ago Craft.co Show details

Palatin Technologies $60.3 M in annual revenue in FY 2019. See insights on Palatin Technologies including office locations, competitors, revenue, financials, executives, subsidiaries and …

Employees: 18
Type: Public
Founded: 1986
Website: palatin.com

Category: Tech SupportShow more

Palatin Technologies, Inc. (PTN) Company Profile

5 hours ago Stockanalysis.com Show details

Company profile for Palatin Technologies, Inc. (PTN) with a description, list of executives, contact details and other key facts. Company profile for Palatin Technologies, Inc. (PTN) with a description, list of executives, contact details and other key facts. CUSIP Number: 696077304: ISIN Number: US6960774031: Employer ID: 95-4078884: Key

Category: Tech SupportShow more

EIN 954078884 Palatin Technologies Inc, Cranbury, New

4 hours ago Eintaxid.com Show details

Palatin Technologies Inc is a corporation in Cranbury, New jersey. The employer identification number (EIN) for Palatin Technologies Inc is 954078884. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Category: Tech SupportShow more

Palatin Technologies Inc. (PTN): Thanks for the contact info.

2 hours ago Investorshub.advfn.com Show details

Gauging Palatin Technologies’ Risk Factors TipRanks - 9/30/2021 9:10:14 AM: Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 8:21:10 AM Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update PR Newswire (US) - 9/29/2021 7:30:00 AM: Annual Report (10-k) Edgar (US Regulatory) - 9/28/2021 4:44:06 PM

Category: Contact Support, Tech SupportShow more

Palatin Technologies Wiki Finpedia

7 hours ago Finpedia.co Show details

12.29.235

1. The melanocortin system is involved in a large and diverse number of physiologic functions. Therapeutic agents modulating this system may have the potential to treat a variety of conditions and diseases, including sexual dysfunction, obesity and related disorders, pigmentation disorders and inflammation-related diseases. Bremelanotide for HSDD. Palatin is developing subcutaneously administered bremelanotide for the treatment of HSDD in premenopausal women. HSDD is characterized by both a decrease in sexual desire and significant personal distress or interpersonal difficulty as a result of the lack of desire. Bremelanotide is a melanocortin agonist with a mechanism of action which the company believe involves activation of endogenous neuronal pathways in the brain regulating sexual arousal and desire responses. The company completed last patient visits in the efficacy parts of its two pivotal Phase 3 clinical studies of bremelanotide for the treatment of HSDD in premenopausal women i...

Category: Tech SupportShow more

Palatin Technologies Inc Sample Contracts Law Insider

6 hours ago Lawinsider.com Show details

Palatin Technologies Inc – WARRANT TO PURCHASE COMMON STOCK OF PALATIN TECHNOLOGIES, INC.. THIS CERTIFIES THAT, for value received, _____, or its permitted assigns (the “Holder”), is entitled to subscribe for and purchase from Palatin Technologies, Inc., a Delaware corporation, or any successor (the “Company”), in whole or in part, at $0.70 per Warrant Share …

Category: Tech SupportShow more

PTN Institutional Ownership Palatin Technologies, Inc.

7 hours ago Fintel.io Show details

Palatin Technologies, Inc. (US:PTN) has 94 institutional owners and shareholders (aka shareholding pattern) that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,230,611 shares.

Category: Tech SupportShow more

Palatin Technologies Number of Employees 20062021 PTN

6 hours ago Macrotrends.net Show details

Palatin Technologies number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Tech SupportShow more

PTN: Dividend Date & History for Palatin Technologies Inc

5 hours ago Dividend.com Show details

Palatin Technologies Inc [REPORT] PTN vs Benchmark, Sep 2021 Dividend policy None Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases. Contact us About us FAQ DARS Ratings

Category: Tech SupportShow more

Palatin Technologies Stock Price Target and Analyst

6 hours ago Pricetargets.com Show details

(609) 495-2200Palatin Technologies' physical mailing address is 4B Cedarbrook Dr, CRANBURY, NJ 08512-3641, United States. The biopharmaceutical company's listed phone number is (609) 495-2200 and its investor relations email address is [email protected]palatin.com. The official website for Palatin Technologies is www.palatin.com.

Category: Tech SupportShow more

Palatin Technologies Inc 10Q realdealdocs.com

5 hours ago Realdealdocs.com Show details

(609) 495-2200(609) 495-2200 (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for

Category: Tech SupportShow more

PALATIN TECHNOLOGIES, INC. : Shareholders Board Members

4 hours ago Marketscreener.com Show details

Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems.

Category: Tech SupportShow more

Palatin Technologies Inc. (PTN): The stock medium term

Just Now Baxterreport.com Show details

The total number of common shares currently owned by the public is 237.02 million. PTN does have institutional investors; and they hold 9.90% of the stock. Palatin Technologies Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Category: Tech SupportShow more

Palatin Technologies, Inc. Reports Fourth Quarter and

8 hours ago Bloomberg.com Show details

019-09-12Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results per common share Weighted average number of common shares outstanding used …

Category: Tech SupportShow more

PTN Stock Palatin Technologies Inc SEC Filings

9 hours ago Sec.report Show details

Ticker: PTN. documents---0.00084090232849121. Palatin Technologies Inc is regulated by the U.S. Security and Exchange Commission and incorporated in the state of New Jersey. Palatin Technologies Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st.

Category: Tech SupportShow more

PTN Company Profile for PALATIN TECHNOLOGIES, INC. MSN

Just Now Msn.com Show details

Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and

Category: Tech SupportShow more

We Analyzed the Future Direction of Palatin Technologies

3 hours ago Newsheater.com Show details

Palatin Technologies Inc. (AMEX:PTN) went up by 8.95% from its latest closing price compared to the recent 1-year high of $1.30. The company’s stock price has collected 0.38% of gains in the last five trading sessions. Press Release reported 3 hours ago that Palatin Announces Positive End-of-Phase 2 Meeting with FDA on PL9643 for the Treatment of Dry Eye Disease

Category: Tech SupportShow more

Palatin Technologies Inc. (AMEX: PTN): A Competitive

9 hours ago Marketingsentinel.com Show details

In the last trading session, 1.53 million shares of the Palatin Technologies Inc. (AMEX:PTN) were traded, and its beta was 1.16. Most recently the company’s share price was $0.41, and it changed around -$0.01 or -2.40% from the last close, which brings the market valuation of the company to $98.10

Category: Tech SupportShow more

Palatin Reports Fourth Quarter and Full Year Fiscal Year

9 hours ago Wfmz.com Show details

CRANBURY, N.J., Sept. 29, 2021 /PRNewswire/ -- Palatin Technologies, Inc., (NYSE American: PTN), a biopharmaceutical company developing first …

Category: Contact NumberShow more

PTN WACC % Palatin Technologies GuruFocus.com

1 hours ago Gurufocus.com Show details

021-08-25As of today (2021-08-25), Palatin Technologies's weighted average cost of capital is 7.91%.Palatin Technologies's ROIC % is -533.50% (calculated using TTM income statement data). Palatin Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Category: Tech SupportShow more

PALATIN TECHNOLOGIES, INC. : PTN Stock Price

6 hours ago Marketscreener.com Show details

Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. The Company’s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with

Category: Tech SupportShow more

Palatin Reports Financial Results for the Third Fiscal

5 hours ago Finance.yahoo.com Show details

Contact Us . Contact Us PALATIN TECHNOLOGIES, INC. and Subsidiary. Nio delivered a record number of 10,628 vehicles in total in September, up 125.7% year over year.

Category: Contact NumberShow more

About Title21 Health Solutions

1 hours ago Title21.com Show details

Lynn Fischer, Chief Executive Officer. Since 2001, Title21 Health Solutions has been dedicated to delivering easy-to-use, flexible and integrated technology to support health sciences organizations achieve compliance, gain efficiencies and ensure high quality, ultimately, to support improvement in patient safety and care.

Category: Contact NumberShow more

Palatin Reports Fourth Quarter and Full Year Fiscal Year

1 hours ago Finance.yahoo.com Show details

Palatin Technologies, Inc., (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor

Category: Contact NumberShow more

Potential In Palatin Technologies? YouTube

3 hours ago Youtube.com Show details

Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significan

Category: Tech SupportShow more

Insider Trading Activities at Palatin Technologies Inc (PTN)

4 hours ago Insider-monitor.com Show details

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Palatin Technologies Inc (PTN) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Palatin Technologies Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 911216.

Category: Tech SupportShow more

PTN Palatin Technologies Stock Interactive Chart

Just Now Barchart.com Show details

The number of points the security must move before a new brick is formed. Column : Much like Line and Area charts, a Column chart plots a vertical bar for the close. High/Low Price Markers: Charts are designed to indicate the high and low bars for the visible data range using a small "arc" on two bars:

Category: Tech SupportShow more

Palatin Announces Adjournment of Annual Meeting of

4 hours ago Stocktitan.net Show details

Palatin encourages any stockholder that has not yet voted its shares on Proposal 3 or is uncertain if their shares have been voted on Proposal 3 to contact their broker or bank. The Board of Directors and management requests stockholders as of the record date, April 13, 2021 , to please vote their proxies as soon as possible, but no later than

Category: Contact NumberShow more

Palatin Technologies Does Earnings Surprise History Hold

1 hours ago Stockmarketdaily.co Show details

Earnings and Valuation of Palatin Technologies (NYSEAMERICAN:PTN. Earnings for Palatin Technologies are expected to grow in the coming year, from ($0.09) to ($0.07) per share. The P/E ratio of Palatin Technologies is -12.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Category: Tech SupportShow more

Palatin Technologies PE Ratio 20062021 PTN MacroTrends

5 hours ago Macrotrends.net Show details

Current and historical p/e ratio for Palatin Technologies (PTN) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Category: Tech SupportShow more

Palatin Technologies, Inc. 10K Sep. 28, 2021 4:43 PM

9 hours ago Seekingalpha.com Show details

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date (September 24, 2021): 231,258,137 Palatin Technologies® and

Category: Tech SupportShow more

Palatin Technologies 2021 Investment PTN Macroaxis

6 hours ago Macroaxis.com Show details

Palatin Technologies is selling for 0.44 as of the 30th of September 2021. This is a -6.38 percent decrease since the beginning of the trading day. The stock's open price was 0.47. Get the latest Palatin Technologies detailed stock quotes, stock trade data, stock price info, and performance analysis, including Palatin Stock investment advice, charts, stats and more.

Category: Tech SupportShow more

PTN Stock Price Palatin Technologies Inc. Stock Quote (U

7 hours ago Marketwatch.com Show details

Palatin Technologies, Inc. (PTN) Reports Q2 Loss, Lags Revenue Estimates Feb. 17, 2021 at 8:45 a.m. ET on Zacks.com Palatin (PTN) Jumps: Stock Rises 8.7%

Category: Tech SupportShow more

PTN Short Interest Ratio and Volume (Palatin Technologies)

6 hours ago Marketbeat.com Show details

Short interest is the volume of Palatin Technologies shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 5,430,000 shares of PTN short. 2.60% of Palatin Technologies' shares are currently sold short. Learn More. on Palatin Technologies' current short interest.

Category: Tech SupportShow more

Palatin Technologies, Inc. (PTN) Q1 2021 Earnings Call

1 hours ago News.alphastreet.com Show details

Palatin Technologies, Inc. Q1 2021 earnings call dated Nov. 17, 2020Corporate Participants: Carl Spana — President and Chief Executive Officer. Stephen T. Wills — Executive Vice President, Chief Financial Officer and Chief Operating Officer. Analysts: John Newman — Canaccord Genuity — Analyst. Joseph Pantginis — H.C. Wainwright & Co. — Analyst

Category: Tech SupportShow more

Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q4 2021

8 hours ago Seekingalpha.com Show details

Palatin Technologies, Inc. (NYSE:PTN) Q4 2021 Earnings Conference Call September 29, 2021, 11:00 AM ET Company Participants Carl Spana - President & CEO Steve Wills - …

Category: Tech SupportShow more

AMAG and Palatin Announce Rekynda™ Data Presentations at

7 hours ago Amagpharma.com Show details

WALTHAM, Mass. and CRANBURY, N.J., Feb. 27, 2017 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) together with Palatin Technologies, Inc. (NYSE MKT:PTN) announced that additional results from the Phase 3 RECONNECT Studies (301, 302) of Rekynda™ (bremelanotide) were presented at the International Society for the Study of Women’s Sexual Health …

Category: Contact NumberShow more

Palatin Reports Financial Results for the Third Fiscal

6 hours ago Prnewswire.com Show details

Weighted average number of common shares outstanding used 234,449,813. PALATIN TECHNOLOGIES, INC. and Subsidiary. Consolidated Balance Sheets (unaudited) March 31, 2021 Contact Cision

Category: Contact NumberShow more

Palatin To Report Fourth Quarter And Fiscal Year End 2021

Just Now Forbesalert.com Show details

CRANBURY, N.J., Sept. 24, 2021 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2021 operating results on Wednesday, September 29, 2021, before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on September 29, …

Category: Contact NumberShow more

ptn_10q SEC.gov HOME

7 hours ago Sec.gov Show details

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date (May 8, 2020): 229,258,400 Nature of Business - Palatin Technologies, Inc. (“Palatin” or the “Company”) is a specialized biopharmaceutical company developing first-in-class medicines based on molecules

Category: Home PhoneShow more

Contact Us Best Peptide Supplier Paradigm Peptides

Just Now Paradigmpeptides.com Show details

Paradigm Peptides was founded in 2014 to help people get the SARMS, peptides, and other research chemicals they need. We have since partnered with a number of well-established U.S. based… Read more about Paradigm Peptides.

Category: Contact SupportShow more

Palatin Technologies Inc. (AMEX: PTN) Stock: Performance

5 hours ago Marketingsentinel.com Show details

In the last trading session, 4.34 million Palatin Technologies Inc. (AMEX:PTN) shares changed hands as the company’s beta touched 1.20. With the company’s per share price at $0.49 changed hands at $0.01 or 3.31% during last session, the …

Category: Tech SupportShow more

Bremelanotide Wikipedia

Just Now En.wikipedia.org Show details

The medication is a peptide and acts as an activating the melanocortin receptors. Bremelanotide was approved for medical use in the United States in 2019. It was developed by Palatin Technologies. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What's the stock price of Palatin Technologies Inc?

Stock Investors Aren’t Happy. Palatin (PTN) to Report Q2 Earnings: What's in the Cards? Has Palatin Technologies (PTN) Outpaced Other Medical Stocks This Year?

Who is the CFO of Palatin Technologies?

The Executive VP and CFO of Palatin Technologies Inc (PTN) is Buying Shares. Yesterday, the Executive VP and CFO of Palatin Technologies Inc (PTN), Stephen Wills, bought shares of PTN for $43K.

Who is the executive vice president of Palatin?

With me on the call today is Steve Wills, Palatin’s Executive Vice President, Chief Financial Officer and Chief Operating Officer. On today’s call, we will provide financial and operating updates. We sincerely hope that you and your families are safe and healthy as you deal with the life-altering changes brought about by the COVID-19 pandemic.

Is there a palatin stock on the watchlist?

There are currently no items in this Watchlist. Create a list of the investments you want to track. Something went wrong while loading Watchlist. Another Women’s Libido Drug, Vyleesi, Won FDA Approval. Stock Investors Aren’t Happy. Palatin (PTN) to Report Q2 Earnings: What's in the Cards?

Popular Brands

Pfizer
Paypal
Prosus